Translate this page into:
Juxtaglomerular Cell Tumor: A Distinct Mesenchymal Tumor of Kidney
Address for correspondence: Dr. Hafsa Elouazzani, Department of Pathology, Ibn Sina Hospital, Rabat, Morocco. E-mail: hafoussa02@hotmail.fr
-
Received: ,
Accepted: ,
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Juxtaglomerular cell tumor (JGCT) is an unusual mesenchymal entity of the kidney. It is a benign renin-secreting tumor causing hypertension and hypokalemia due to secondary hyperaldosteronism. It is curable if it is discovered early and surgically removed, but may cause a fatal outcome usually due to complications of associated hypertension.
Keywords
Juxtaglomerular cell
kidney
renin
INTRODUCTION
Juxtaglomerular cell tumor (JGCT), also known as reninoma, is an extremely rare kidney tumor of the juxtaglomerular cells that typically secrete renin. It often causes severe hypertension that is difficult to control in young adults. It was first described, in 1967, by Robertson et al., and was first named, in 1968, by Kihara et al. Since then, approximately 100 case reports have been published. It is generally considered benign, but its malignant potential is uncertain.[1]
We report a case of renin secreting tumor diagnosed after nephrectomy through histological and immunohistochemical investigations.
A 35-year-old woman who suffered from hypertension for 3 years that was poorly controlled by medical treatment with angiotensin converting enzyme (ACE) inhibitors was admitted to our institute with a blood pressure of 140/80 mmHg. Laboratory tests showed hypokalemia with a potassium level of 2.63 mmol/l (normal range 3.6-5 mmol/l).
RADIOLOGICAL FEATURES
Renal ultrasonograpy showed a round cortical lesion in the right kidney. It was well-circumscribed with heterogenous echogenicity [Figure 1a]. Abdominal computed tomography revealed a low-density tissue lesion indicating a tumor in the right kidney [Figure 1b]. Thus, an open nephrectomy was arranged.
PATHOLOGICAL FEATURES
In the pathological examination, the surgical specimen showed a yellow tan color and mid-renal lesion (4 cm in diameter). It was well-circumscribed and bound by a thin fibrous capsule.
Microscopically, the tumor consisted of sheets of polygonal and spindle shaped cells with a central regular nucleus. A complex vascular hemangiopericytic pattern and rare tubular elements entrapped were also present [Figure 2].
In the immunohistochemical investigation, the tumor cells were found to be immunoreactive for renin, vimentin, and Cluster of Differentiation molecule 34 (CD34) [Figure 3].
These pathological features allowed the diagnosis of JGCT. The postoperative course was uneventful with correction of blood pressure and hypokalemia.
DISCUSSION
The first example of a JGCT was reported in 1967 by Roberston et al.,[1] who described a young male patient with hypertension and a small renal neoplasm. The following year, Kihala et al.,[1] reported a similar neoplasm in a young female patient and proposed the term “juxtaglomerular cell tumor”.[2] Since then, approximately 100 case reports have been published.[1] The majority of these patients are women between the ages of 20 and 30 years.[13]
The diagnosis of JGCT is usually suspected in patients with uncontrolled hypertension, marked hypokalemia, and hyperaldosteronism, although one patient had normal blood pressure.[2]
In our case, the symptoms were hypertension with discreet hypokalemia. Tests to determine aldosteronism were not conducted and the final diagnosis was made after surgery based on histological features.
In such a context, radiological studies are often helpful in ruling out other causes of hypertension. Renal arteriography shows the majority of JGCT to be hypervascular and helps to rule out renal artery stenosis.
Computed tomography shows a hypovascular and solid mass in most cases. Renal vein catheterization and selective measurement of renin values may help to detect small tumors.[2]
Grossly, JGCT is a solid, well-circumscribed lesion that has a yellow – tan color. The tumor is usually smaller than 3 cm in diameter, but cases ranging from 2 mm to 9 cm have been reported. Histologically, it is made of sheets of polygonal or spindle shaped tumor cells with central round regular nuclei, distinct cell borders, and abundant granular eosinophilic cytoplasm. Typically, tumors have a complex vascular hemangiopericytic pattern.[3] Papillary architecture, microcystic pattern, and prominent tubular elements, either neoplastic or entrapped, are also present.[34] Marked nuclear atypia and mitotic activity are uncommon.[1] It is important to distinguish these morphological features from those seen in glomus tumor, hemangiopericytoma, metanephric adenoma, papillary renal cell carcinoma, collecting duct carcinoma, urothelial carcinoma, renal epithelioid angiomyolipoma, and Wilms’ tumor.[15] In these cases, immunohistochemical investigation and ultrastructural studies using electronic microscopy are necessary.
JGCTs are immunoreactive for renin, actin, vimentin, and CD34. Ultrastructural features include abundant rough endoplasmic reticulum, a well-developed Golgi apparatus, and numerous peripherally located sharply angulated rhomboid renin protogranules.[3]
Majority of the cases with JGCT are benign, and neither local recurrence nor metastasis has occurred after either radical or partial nephrectomy. However, a few metastatic cases of JGCT have been reported.[67] The complete tumor resection by radical or partial nephrectomy is the best modality for JGCTs. Antihypertensive agents should be the treatment for hypertension until accurate diagnosis is made. Blood pressure and plasma renin level usually normalize after nephrectomy.[8]
CONCLUSION
In summary, primary JGCT is a distinct mesenchymal tumor entity distinct from other renal tumors. There are only a few genetic studies of JGCT because of the rarity of this disease. It is a benign tumor, but may affect the vital prognosis due to complications of associated hypertension.[9]
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/33/135482
Source of Support: Nil
Conflict of Interest: None declared.
REFERENCES
- Review of juxtaglomerular cell tumor with focus on pathobiological aspect. Diagn Pathol. 2011;6:80.
- [Google Scholar]
- Adult renal tumors: Juxtaglomerular cell tumour. In: Carter D, Greenson JK, Reuter VE, Stoler MH, Mills SE, eds. Sternberg's Diagnostic Surgical Pathology Vol 2. (5th ed). 2010. p. :72-3.
- [Google Scholar]
- Juxtaglomerular cell tumour. In: WHO Classification Tumours of the Urinary System and Male Genital Organs (4th ed). Lyon: IARC Press; 2004. p. :72-3.
- [Google Scholar]
- A case of juxtaglomerular cell tumor with novel histologic features. Int J Surg Pathol. 2011;19:65-70.
- [Google Scholar]
- Juxtaglomerular cell tumor of the kidney: Case report and differential diagnosis with emphasis on pathologic and cytopathologic features. Int J Surg Pathol. 2011;19:93-8.
- [Google Scholar]
- Metastatic juxtaglomerular cell tumor in a 52-year old man. Am J Surg Pathol. 2004;28:1098-102.
- [Google Scholar]
- Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome. J Clin Oncol. 2013;31:e240-2.
- [Google Scholar]
- Hypertension due to a renin-secreting juxtaglomerular cell tumor. Am J Hypertens. 2008;21:1359-61.
- [Google Scholar]
- Juxtaglomerular body tumor: A rare occult but curable cause of lethal hypertension. Hum Pathol. 1974;5:236-40.
- [Google Scholar]